Issue 43, 2022

Novel conjugated small molecule-based nanoparticles for NIR-II photothermal antibacterial therapy

Abstract

Single organic small molecule-based nanoparticles (CNPs) with strong responses within the NIR-II (1000–1350 nm) bio-window were prepared, and successfully applied as a highly efficient photothermal antibacterial agent for the first time. CNPs exhibit an outstanding bacteria inhibition efficiency of almost 100% against Staphylococcus aureus (S. aureus) with a high photothermal conversion efficiency (PTCE) of circa 49% under NIR-II laser irradiation (1064 nm) for 8 min.

Graphical abstract: Novel conjugated small molecule-based nanoparticles for NIR-II photothermal antibacterial therapy

Supplementary files

Article information

Article type
Communication
Submitted
11 Feb 2022
Accepted
02 May 2022
First published
02 May 2022

Chem. Commun., 2022,58, 6340-6343

Novel conjugated small molecule-based nanoparticles for NIR-II photothermal antibacterial therapy

W. Jia, F. Huang, Q. Zhang, L. Zhao, C. Li and Y. Lu, Chem. Commun., 2022, 58, 6340 DOI: 10.1039/D2CC00863G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements